Why radioiodine remnant ablation is right for most patients with differentiated thyroid carcinoma

Eur J Nucl Med Mol Imaging. 2009 Mar;36(3):343-6. doi: 10.1007/s00259-008-0997-5.
No abstract available

Publication types

  • Editorial
  • Review

MeSH terms

  • Cell Differentiation
  • Combined Modality Therapy
  • Humans
  • Iodine Radioisotopes / adverse effects
  • Iodine Radioisotopes / therapeutic use*
  • Neoplasm Staging
  • Thyroid Neoplasms / pathology
  • Thyroid Neoplasms / radiotherapy*
  • Thyroid Neoplasms / surgery

Substances

  • Iodine Radioisotopes